4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-21-032250
Director bought 500 shares at $58.15 ($29,075)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2021-05-12 | Purchase | +500 | $58.15 | $29,075 | 420,998 | I |
| Open-market purchases · 500 sh · avg $58.15 · $29,075 | |||||||
Loading xslF345X03/doc4.xml…